{
    "organizations": [],
    "uuid": "7cc482a595504c8ed7b58bed135c61e30e761035",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-redhill-biopharma-q4-basic-loss-pe/brief-redhill-biopharma-q4-basic-loss-per-ordinary-share-0-05-idUSASB0C6Y7",
    "ord_in_thread": 0,
    "title": "BRIEF-Redhill Biopharma Q4 Basic Loss Per Ordinary Share $0.05",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Redhill Biopharma Ltd:\n* Q4 REVENUE ROSE 31 PERCENT TO $2.0 MILLION * QTRLY BASIC LOSS PER ORDINARY SHARE $0.05 * CASH BALANCE AS OF DECEMBER 31, 2017 WAS $46.2 MILLION, A DECREASE OF $20 MILLION, COMPARED TO $66.2 MILLION AS OF DECEMBER 31, 2016 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T20:18:00.000+02:00",
    "crawled": "2018-02-23T15:44:39.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "redhill",
        "biopharma",
        "ltd",
        "q4",
        "revenue",
        "rose",
        "percent",
        "million",
        "qtrly",
        "basic",
        "loss",
        "per",
        "ordinary",
        "share",
        "cash",
        "balance",
        "december",
        "million",
        "decrease",
        "million",
        "compared",
        "million",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}